Bionik Laboratories Corp. said a majority of its voting capital stockholders approved a reverse split of the company's common stock at a ratio of up to 1 for 150.

The Toronto-based robotics company said it received consent from stockholders, representing about 58.57% of its outstanding shares of voting capital stock, for the reverse stock split.

The board had approved the reverse stock split in July.